0000950170-23-071270.txt : 20231218
0000950170-23-071270.hdr.sgml : 20231218
20231218215703
ACCESSION NUMBER: 0000950170-23-071270
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231214
FILED AS OF DATE: 20231218
DATE AS OF CHANGE: 20231218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parkinson David Ross
CENTRAL INDEX KEY: 0001451935
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37410
FILM NUMBER: 231495495
MAIL ADDRESS:
STREET 1: C/O THRESHOLD PHARMACEUTICALS, INC.
STREET 2: 170 HARBOR WAY SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ESSA Pharma Inc.
CENTRAL INDEX KEY: 0001633932
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
BUSINESS PHONE: (778) 331-0962
MAIL ADDRESS:
STREET 1: SUITE 720
STREET 2: 999 WEST BROADWAY
CITY: VANCOUVER
STATE: A1
ZIP: V5Z 1K5
4
1
ownership.xml
4
X0508
4
2023-12-14
0001633932
ESSA Pharma Inc.
EPIX
0001451935
Parkinson David Ross
C/O ESSA PHARMA INC.
999 WEST BROADWAY, SUITE 720
VANCOUVER
A1
V5Z 1K5
BRITISH COLUMBIA, CANADA
true
true
false
false
Chief Executive Officer
false
Common Shares
2023-12-14
4
P
false
9223
2.30
A
65675
D
The amount reflects the acquisition of shares pursuant to the ESSA Pharma Inc. Employee Stock Purchase Plan.
/s/ David Parkinson
2023-12-18